Cargando…

Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma

SIMPLE SUMMARY: The potential role of positron emission tomography/computed tomography with fluorodeoxyglucose (FDG PET/CT) for assessing the extent of Kaposi sarcoma is not well studied. We analyzed FDG PET/CTs performed on 75 patients referred to our department for Kaposi sarcoma staging or restag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pesqué, Louise, Delyon, Julie, Lheure, Coralie, Baroudjian, Barouyr, Battistella, Maxime, Merlet, Pascal, Lebbé, Céleste, Vercellino, Laetitia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102885/ https://www.ncbi.nlm.nih.gov/pubmed/35565319 http://dx.doi.org/10.3390/cancers14092189

Ejemplares similares

18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors
por: Rivas, Alexia, et al.
Publicado: (2022)

Systemic Treatment Initiation in Classical and Endemic Kaposi’s Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study
por: Benajiba, Lina, et al.
Publicado: (2021)

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma
por: Reger de Moura, Coralie, et al.
Publicado: (2019)

Endemic Kaposi’s Sarcoma
por: Zeinaty, Perla El, et al.
Publicado: (2023)

Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care
por: Louveau, Baptiste, et al.
Publicado: (2019)

Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
por: HERMS, Florian, et al.
Publicado: (2022)

Nivolumab-induced alopecia areata: A reversible factor of good prognosis?
por: Lakhmiri, Myriam, et al.
Publicado: (2018)

Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients
por: Cuzzubbo, Stefania, et al.
Publicado: (2020)

Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans
por: Beaziz, Jessica, et al.
Publicado: (2021)

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
por: Gauci, Marie-Léa, et al.
Publicado: (2021)

Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes
por: Nguyen, Thuy Thi, et al.
Publicado: (2020)

Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases
por: Tétu, Pauline, et al.
Publicado: (2020)

FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma
por: Tétu, Pauline, et al.
Publicado: (2020)

Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
por: Vercellino, Laetitia, et al.
Publicado: (2022)

PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
por: Beldi-Ferchiou, Asma, et al.
Publicado: (2016)

Kaposi's sarcoma.
por: Dalgleish, A. G.
Publicado: (1991)

EGFR is involved in dermatofibrosarcoma protuberans progression to high grade sarcoma
por: Osio, Amélie, et al.
Publicado: (2018)

RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy
por: Jebali, Ahlem, et al.
Publicado: (2021)

Human Herpesvirus 8 (HHV8) Sequentially Shapes the NK Cell Repertoire during the Course of Asymptomatic Infection and Kaposi Sarcoma
por: Dupuy, Stéphanie, et al.
Publicado: (2012)

KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi’s sarcoma
por: Cavallin, Lucas E, et al.
Publicado: (2010)

Sarcoma de Kaposi /
por: Jiménez Jiménez, Leticia
Publicado: (1995)

Kaposi's Sarcoma in Nigeria
por: Maclean, Catherine M. U.
Publicado: (1963)

Gastric Kaposi’s sarcoma
por: Teixeira, Veluma Lopes, et al.
Publicado: (2015)

Bronchopulmonary Kaposi's sarcoma
por: Bashar, Nada, et al.
Publicado: (2015)

Kaposi sarcoma of the eyelid
por: Chraibi, Fouad, et al.
Publicado: (2018)

Imaging of Kaposi sarcoma
por: Addula, Dhivya, et al.
Publicado: (2021)

Disseminated Kaposi Sarcoma
por: Goyack, Laura E., et al.
Publicado: (2021)

Epidemiology of Kaposi’s Sarcoma
por: Grabar, Sophie, et al.
Publicado: (2021)

Disseminated Kaposi Sarcoma
por: Ma, Jin-Yuan, et al.
Publicado: (2022)

Glottic Kaposi's sarcoma
por: Xie, YongXiang, et al.
Publicado: (2023)

Human herpesvirus 8 in Kaposi's sarcoma and Kaposi's sarcoma-mimicking vascular tumors.
por: Kang, G. H., et al.
Publicado: (1998)

Therapeutic Perspectives in the Systemic Treatment of Kaposi’s Sarcoma
por: Valantin, Marc-Antoine, et al.
Publicado: (2022)

Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues
por: Sun, Rui, et al.
Publicado: (2017)

Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma
por: Jary, Aude, et al.
Publicado: (2021)

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors
por: Louveau, Baptiste, et al.
Publicado: (2019)

Sarcomas other than Kaposi's sarcoma in immunodeficiency
por: Bhatia, Kishor, et al.
Publicado: (2012)

Kaposi Sarcoma of Lymph Nodes
por: Bhana, D., et al.
Publicado: (1970)

Kaposi sarcoma in unusual locations
por: Pantanowitz, Liron, et al.
Publicado: (2008)

Acroangiodermatitis (Pseudo-Kaposi sarcoma)
por: Singh, Satyendra Kumar, et al.
Publicado: (2014)

Isolated gastric Kaposi’s sarcoma
por: Costa, Dalila, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1t01qi1r2apoeetka98jqdm9mt